COVID-19 Among Patients With Multiple Sclerosis
A Systematic Review
Citation Manager Formats
Make Comment
See Comments
See original article:

Article Information
- Received October 6, 2020
- Accepted in final form February 5, 2021
- First Published May 20, 2021.
Author Disclosures
- Mahdi Barzegar, MD (barzegar_mahdi73{at}yahoo.com),
- Omid Mirmosayyeb, MD (omid.mirmosayyeb{at}gmail.com),
- Mahsa Gajarzadeh, MD, PhD (m.ghajarzadeh{at}gmail.com),
- Alireza Afshari-Safavi, PhD (alireza.afsharisafavi{at}gmail.com),
- Nasim Nehzat, PharmD (n.nehzat96{at}gmail.com),
- Saeed Vaheb (saeedvaheb.sv{at}gmail.com),
- Vahid Shaygannejad, MD and
- Amir-Hadi Maghzi, MD (amaghzi{at}bwh.harvard.edu)
- Mahdi Barzegar, MD (barzegar_mahdi73{at}yahoo.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Omid Mirmosayyeb, MD (omid.mirmosayyeb{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mahsa Gajarzadeh, MD, PhD (m.ghajarzadeh{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alireza Afshari-Safavi, PhD (alireza.afsharisafavi{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nasim Nehzat, PharmD (n.nehzat96{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Saeed Vaheb (saeedvaheb.sv{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vahid Shaygannejad, MD and
None
NONE
None
International Journal of Preventive Medicine, Editorial board, 2020-2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Amir-Hadi Maghzi, MD (amaghzi{at}bwh.harvard.edu)
NONE
NONE
NONE
Multiple Sclerosis and Related Disorders, Editorial Board, 2012
NONE
NONE
Currently Employed by Biogen. However, at time of conception, analysis, preparation, submission and submission of revisions was employed by Brigham and Women's Hospital, Harvard Medical School.
NONE
NONE
NONE
NONE
NONE
NONE
Pilot grant from Women's Brain Initiative, Brigham and Women's Hospital.
clinician-scientist development fellowship from the National MS Society and American Brain Foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.B., O.M., N.N., S.V., V.S.), School of Medicine, Isfahan University of Medical Sciences; Universal Council of Epidemiology (UCE) (M.G.), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences; Department of Biostatistics and Epidemiology (A.A.-S.), Faculty of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran; and Ann Romney Center for Neurologic Diseases (A.-H.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Correspondence
Dr. Shaygannejad v.shaygannejad{at}gmail.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
SARS-CoV-2 Infection in Multiple SclerosisResults of the Spanish Neurology Society RegistryGeorgina Arrambide, Miguel Ángel Llaneza-González, Lucienne Costa-Frossard França et al.Neurology: Neuroimmunology & Neuroinflammation, June 24, 2021 -
Article
A New England COVID-19 Registry of Patients With CNS Demyelinating DiseaseA Pilot AnalysisKelli M. Money, Ashmanie Mahatoo, Soleil Samaan et al.Neurology: Neuroimmunology & Neuroinflammation, August 02, 2021 -
Article
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North AmericaFrom the COViMS RegistryScott D. Newsome, Anne H. Cross, Robert J. Fox et al.Neurology: Neuroimmunology & Neuroinflammation, August 24, 2021 -
Article
Incidence and Impact of COVID-19 in MSA Survey From a Barcelona MS UnitMaria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández et al.Neurology: Neuroimmunology & Neuroinflammation, January 27, 2021